GMIM
CYTK icon

General Motors Investment Management’s Cytokinetics CYTK Stock Holding History

General Motors Investment Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-17,184
Closed -$117K – 156
2015
Q1 		$117K Hold
17,184
– – 0.01% 931
2014
Q4 		$138K Hold
17,184
– – 0.01% 880
2014
Q3 		$60K Hold
17,184
– – ﹤0.01% 915
2014
Q2 		$82K Buy
+17,184
New +$105K 0.01% 922

Other funds holding CYTK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

General Motors Investment Management's CYTK Position: Q2 2015 in Review

General Motors Investment Management sold out of Cytokinetics (CYTK) in Q2 2015, closing a stake of 17,184 shares — an estimated $117K sold.

General Motors Investment Management first reported a position in CYTK in Q2 2014 and held it in 4 quarters. The position peaked at $138K in Q4 2014. 99 funds tracked by Wall St. Rank hold CYTK as of Q2 2015.

  • General Motors Investment Management reported no remaining Cytokinetics position as of Q2 2015 after selling out during the quarter.
  • General Motors Investment Management sold 17,184 Cytokinetics shares in Q2 2015, an estimated $117K.
  • General Motors Investment Management first reported a position in Cytokinetics in Q2 2014 and held it in 4 quarters.
  • General Motors Investment Management's Cytokinetics position peaked at $138K in Q4 2014.
  • 99 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2015.

Based on General Motors Investment Management's 13F filing for Q2 2015, filed 5 Aug 2015.